Skip to main content
Premium Trial:

Request an Annual Quote

Burroughs Wellcome Awards Scripps Florida Scientist $500K for Hepatitis Research

NEW YORK (GenomeWeb News) – An infectious disease researcher at Scripps Florida will use a $500,000 award from the Burroughs Wellcome Fund to study RNA replication in hepatitis C and other aspects of the disease, Scripps Florida said Wednesday.
 
A professor in Scripps Florida’s Infectology Department, Timothy Tellinghuisen, received the Investigators in the Pathogenesis of Infectious Disease Award for 2008, which will be spread out over the course of five years.
 
“We plan to use the award to expand our work with hepatitis C, particularly in the area of RNA replication and virus assembly to determine if these are productive targets for new therapeutic development," Tellinghuisen said in a statement.
 
Tellinghuisen’s research is focused on developing new and more effective drugs to combat hepatitis C, which affects more than 170 million people worldwide each year and currently has limited treatment options.
 
"This award provides risk capital for investigators to use new and creative approaches to study the interaction between the host and the microbe,” Burroughs Wellcome Fund President, Enriqueta Bond, said in a statement.
 
To be considered for the award, candidates must hold tenure-track faculty positions and must be nominated by institutions in the US or in Canada.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.